Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 26, 2026Acta cardiologica. Supplementum

A null finding is not a negative finding: intramuscular penicillin prophylaxis and the perils of underpowered inference in mild rheumatic heart disease

View Full Paper
Ask AI
Bookmark
Share

Authors

MIMinahil Iqbal

Discussion

Loading...

Member takes

Overview

Methodological commentary reveals the risk of misinterpreting null findings in mild rheumatic heart disease, highlighting the perils of stopping penicillin prophylaxis based on underpowered data.

Key Points

  • To address the inferential risks of interpreting null trial results as evidence of no therapeutic effect when evaluating intramuscular penicillin prophylaxis in mild rheumatic heart disease.
  • Critically analyzed statistical power, sample size constraints, and clinical inference surrounding secondary penicillin prophylaxis trials for mild rheumatic heart disease.
  • Demonstrates that a statistically non-significant result in an underpowered trial represents an inconclusive null finding rather than evidence of therapeutic equivalence or lack of benefit.
  • Warns that premature discontinuation of intramuscular penicillin prophylaxis based on underpowered inferences places patients with mild rheumatic heart disease at risk of preventable progression.

Cite This Study

Minahil Iqbal (2026) studied this question.

synapsesocial.com/papers/6a8e9b92451774b83f3b461bhttps://doi.org/10.1080/00015385.2026.2722414
View Full Paper
Ask AI
Bookmark
Share